Amphion Innovations (AMP)

 

Latest News

Motif Bio notes statement from Amphion Innovations

RNS Number: 9502O Motif Bio PLC 23 May 2018 Motif Bio plc ("Motif Bio" or the "Company") Motif Bio notes statement from Amphion Innovations Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, notes the announcement made today via RNS by Amphion Innovations plc ("Amphion"...

Sale of Partner Company Shares

RNS Number: 9386O Amphion Innovations PLC 23 May 2018 Amphion Innovations plc ("Amphion" or "the Company") Sale of Partner Company Shares London and New York: Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that 8,896,034 shares in Partner Company, Motif Bio plc ("Motif"), have b...

Directorate Change

RNS Number: 5404L Amphion Innovations PLC 20 April 2018 Amphion Innovations plc ("Amphion" or "the Company") Directorate Change London and New York, 20 April 2018 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that Miroslaw Izienicki and Richard Mansell-Jones have resigned as N...

AIM Admission & First Day of Dealings

RNS Number: 3251J Polarean Imaging PLC 29 March 2018 Polarean Imaging Plc ("Polarean", the "Company" or the "Group") Admission to trading on AIM and First Day of Dealings Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market,...

All News

No news for Amphion Innovations during this period.